These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18239749)

  • 61. [Insufficient evidence for oral glucocorticoids as first-line therapy for acute gout].
    Jacobs JW; Bijlsma JW
    Ned Tijdschr Geneeskd; 2009; 153():A615. PubMed ID: 19785794
    [TBL] [Abstract][Full Text] [Related]  

  • 62. We still don't know how to taper glucocorticoids in rheumatoid arthritis, and we can do better.
    Volkmann ER; Rezai S; Tarp S; Woodworth TG; Furst DE
    J Rheumatol; 2013 Oct; 40(10):1646-9. PubMed ID: 24085754
    [No Abstract]   [Full Text] [Related]  

  • 63. Efficacy and safety of glucocorticoids therapy for IgA nephropathy: a meta-analysis of randomized controlled trials.
    Cheng J; Zhang X; Zhang W; He Q; Tao X; Chen J
    Am J Nephrol; 2009; 30(4):315-22. PubMed ID: 19546530
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Use of glucocorticoids in therapy of rheumatic disease. 1: Value--precautions--choice of drug preparation].
    Kaiser H
    Fortschr Med; 1998 Nov; 116(32):44-5. PubMed ID: 9880952
    [No Abstract]   [Full Text] [Related]  

  • 65. Innovative treatment strategies for patients with rheumatoid arthritis.
    van der Kooij SM; Allaart CF; Dijkmans BA; Breedveld FC
    Curr Opin Rheumatol; 2008 May; 20(3):287-94. PubMed ID: 18388520
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evidence to support or guide glucocorticoid tapering in rheumatoid arthritis is lacking.
    Wallace BI; Wallace DM; Waljee AK; Clauw DJ
    Ann Rheum Dis; 2019 Dec; 78(12):1733-1734. PubMed ID: 31366468
    [No Abstract]   [Full Text] [Related]  

  • 67. [Pathologic bone fractures in patients treated with corticosteroid preparations for long periods of time].
    Vapra A; Kanmer Kh
    Vopr Revm; 1967; 7(3):80-2. PubMed ID: 5620572
    [No Abstract]   [Full Text] [Related]  

  • 68. All patients with rheumatoid arthritis should receive corticosteroids as part of their management.
    Carette S
    J Rheumatol; 2007 Apr; 34(4):656-60. PubMed ID: 17407224
    [No Abstract]   [Full Text] [Related]  

  • 69. Dose-related patterns of glucocorticoid-induced side effects.
    Huscher D; Thiele K; Gromnica-Ihle E; Hein G; Demary W; Dreher R; Zink A; Buttgereit F
    Ann Rheum Dis; 2009 Jul; 68(7):1119-24. PubMed ID: 18684744
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Various scintigraphic aspects of the spleen in rheumatoid arthritis].
    Falcetti E; Spina C; Trinci M; Gospodinof L
    Nunt Radiol; 1968 Oct; 34(10):995-1007. PubMed ID: 5745115
    [No Abstract]   [Full Text] [Related]  

  • 71. Revitalising glucocorticoids for (rheumatoid) arthritis.
    Kirwan JR
    Clin Med (Lond); 2010 Apr; 10(2):159-60. PubMed ID: 20437990
    [No Abstract]   [Full Text] [Related]  

  • 72. The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials.
    Pope JE; Khanna D; Norrie D; Ouimet JM
    J Rheumatol; 2009 Feb; 36(2):254-9. PubMed ID: 19132791
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prednisolone in early rheumatoid arthritis: an antiinvasive effect.
    Harris ED
    Arthritis Rheum; 2005 Nov; 52(11):3324-5. PubMed ID: 16255013
    [No Abstract]   [Full Text] [Related]  

  • 74. [Posterior subcapsular cataract induced by a long term systemic steroid therapy for rheumatoid disease].
    Matsuura H
    Nihon Ganka Kiyo; 1967 Jul; 18(7):800-3. PubMed ID: 5626063
    [No Abstract]   [Full Text] [Related]  

  • 75. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The function of the adrenal cortex in patients with rheumatism and infectious nonspecific polyarthritis and its modification by steroid hormone therapy].
    Zverev ME
    Vopr Revm; 1966; 6(2):41-5. PubMed ID: 5988557
    [No Abstract]   [Full Text] [Related]  

  • 77. Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis.
    Book C; Karlsson M; Akesson K; Jacobsson L
    Scand J Rheumatol; 2008; 37(4):248-54. PubMed ID: 18612924
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls.
    Laurberg TB; Frystyk J; Ellingsen T; Hansen IT; Jørgensen A; Tarp U; Hetland ML; Hørslev-Petersen K; Hornung N; Poulsen JH; Flyvbjerg A; Stengaard-Pedersen K
    J Rheumatol; 2009 Sep; 36(9):1885-91. PubMed ID: 19684150
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Changing aspects of corticosteroid therapy in rheumatic diseases (proceedings)].
    Jesserer H
    Acta Med Austriaca Suppl; 1976; 3():202. PubMed ID: 1072572
    [No Abstract]   [Full Text] [Related]  

  • 80. Interventions to improve adherence to exercise for chronic musculoskeletal pain in adults.
    Aitken D; Buchbinder R; Jones G; Winzenberg T
    Aust Fam Physician; 2015; 44(1-2):39-42. PubMed ID: 25688958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.